Efficacy of sodium nitroprusside in the treatment of drug-naive subjects in first episode psychosis - An open label study
- PMID: 38761435
- DOI: 10.1016/j.schres.2024.05.010
Efficacy of sodium nitroprusside in the treatment of drug-naive subjects in first episode psychosis - An open label study
Conflict of interest statement
Declaration of competing interest Marcelo P. M. Adelino reports grants and personal fees from Janssen Pharmaceutical, Boehringer-Ingelheim, Novo Nordisk, Acadia Pharmaceutical, NeuromaTherapeutics, Cellavita, LiraNova, Parexel, IQVIA, Azidus, Synova, PPD, ICON. Marcel V. Nunes reports grants and personal fees from Janssen Pharmaceutical, Boehringer-Ingelheim, Novo Nordisk, Acadia Pharmaceutical, NeuromaTherapeutics, Cellavita, LiraNova, Parexel, IQVIA, Azidus, Synova, PPD, ICON. Marielle F. Q. Nunes reports grants and personal fees from Janssen Pharmaceutical, Eli Lilly, Novartis, Boehringer-Ingelheim, Novo Nordisk, Acadia Pharmaceutical, NeuromaTherapeutics, Cellavita, LiraNova, Parexel, IQVIA, Azidus, Synova, PPD, ICON. Lucas C. Quarantini reports consulting fees from Allergan, Abbot, Janssen Pharmaceutical, Libbs, Cristalia and Lundbeck and research fees from Janssen Pharmaceutical, CNPq. No others conflicts of interest declared concerning the publication of this article. Jaime C. E. Hallak is recipient of Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq, Brazil) productivity fellowship (1A). Acioly L. T. Lacerda reports grants and personal fees from Janssen Pharmaceutical, Daiichi Sankyo, Cristalia Produtos Químicos e Farmacêuticos, Libbs, Apsen, Aché Laboratórios, Sanofi-Aventis, Novartis, Eli Lilly, H. Lundbeck A/S, Boehringer-Ingelheim, Novo Nordisk, Acadia Pharmaceutical, Neumora Therapeutics, Cellavita, LivaNova, EMS, Parexel, IQVIA, Azidus, Synova, PPD, Eurofarma, Abbott.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical